Thursday, 5 January 2023

Technological Advancements to Influence Bone And Joint Health Supplements Market Growth 2022-2030: Grand View Research Inc.

 

Bone And Joint Health Supplements Market Growth & Trends 

The global bone and joint health supplements market size is expected to reach USD 3.8 billion by 2030 and is expected to expand at a CAGR of 7.0% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of orthopedic disorders among the geriatric and adult population is one of the major factors driving the market. According to the CDC, around 58.5 million people are diagnosed with arthritis and it is more common in women as compared to men. Also, the increasing burden of arthritis is anticipated to drive the industry during the forecast period. As per the CDC, around 78.4 million adults aged 18 years and above are anticipated to be diagnosed with arthritis. Moreover, the rising geriatric population across the globe is fueling industry growth as the prevalence of orthopedic disorders increases with age. Around 49.6% of people aged above 65 years are diagnosed with arthritis. 

Furthermore, the rising health consciousness, increasing consumer interest in active living, and rising disposable income are among the key factors driving the industry. In addition, increasing awareness regarding micronutrient deficiencies, increasing access to supplements, availability of multiple products, and the increasing number of distribution channels are supporting the growth. 

Moreover, the increasing focus of key companies on various strategies to meet consumer demand is impelling market growth. For instance, in March 2022, Bioiberica entered into a partnership with ByHealth to develop a product for joint health brand “Highflex” in the China market. Furthermore, the manufacturers are developing new supplements in various formulations to attract the consumer base, thereby positively impacting the industry's growth. For instance, in February 2022, Gadot Biochemical Industries launched ‘Cal2Mag’, a new mineral blend combining calcium and magnesium, to specifically target bone health. 

Request a free sample copy or view report summary: Bone And Joint Health Supplements Market Report

Bone And Joint Health Supplements Market Report Highlights

  • The market is anticipated to grow owing to the increasing consumption of supplements for bone health, increasing access to supplements, and rising prevalence of micronutrient deficiencies among adults

  • The vitamin product segment dominated the market in 2021 due to the increasing prevalence of vitamin D deficiency in children and adults. This, in turn, is raising the demand for vitamin supplements to support bone and joint health

  • The capsules formulation segment held the largest share in 2021 owing to its high preference due to the ease of consumption

  • Based on consumer group, the geriatric population segment dominated the market in 2021 owing to the increasing prevalence of arthritis and osteoporosis among the geriatric population and the rising incidence of bone fractures due to osteoporosis

  • By sales channel, in 2021, the bricks and mortar segment held the largest share owing to the presence of a large number of providers, lucrative discounts, and high consumer trust in the direct sales channel

  • North America dominated the market in 2021 due to the increasing number of people suffering from joint disorders and rising awareness regarding healthy and active lifestyle

Access Press Release@ https://www.grandviewresearch.com/press-release/global-bone-joint-health-supplements-market

Bone And Joint Health Supplements Market Segmentation

Grand View Research has segmented the global bone and joint health supplements market based on product, formulation, consumer group, sales channel, and region: 

Bone & Joint Health Supplements Product Outlook (Revenue, USD Million, 2016 - 2030)

  • Vitamins

  • Minerals

  • Collagen

  • Omega-3

  • Glucosamine

  • Others

Bone & Joint Health Supplements Formulation Outlook (Revenue, USD Million, 2016 - 2030)

  • Capsules

  • Tablets

  • Powders

  • Softgels

  • Others

Bone & Joint Health Supplements Consumer Group Outlook (Revenue, USD Million, 2016 - 2030)

  • Infants

  • Children

  • Adults

  • Pregnant Women

  • Geriatric Population

Bone & Joint Health Supplements Sales Channel Outlook (Revenue, USD Million, 2016 - 2030)

  • Bricks And Mortar

    • Direct Selling

    • Chemist/Pharmacies

    • Health Food Shops

    • Hyper Markets

    • Super Markets

  • E-commerce

Bone & Joint Health Supplements Regional Outlook (Revenue, USD Million, 2016 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Italy

    • France

    • Spain

    • Russia

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East Africa

    • South Africa

    • Saudi Arabia

    • UAE

List of Key Players in the Bone And Joint Health Supplements Market

  • Herbalife International of America, Inc.

  • GNC Holdings, Inc.

  • Nature’s Bounty Co.

  • Bayer AG

  • BY-HEALTH Co., Ltd.

  • Amway

  • Basf SE

  • Reckitt Benckiser

  • Vita Life Sciences Ltd.

  • Glanbia Plc

  • Now Foods

  • Pfizer

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

No comments:

Post a Comment

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...